bioRxivPathology
Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of Covid-19 death
L. Szekely, B. Bozoky, M. Bendek, M. Ostad, P. Lavignasse, L. Haag, J. Wu, X. Jing, S. Gupta, E. Saccon, A. Sonnerborg, Y. Cao, M. Bjornstedt, A. Szakos
Abstract
Most Covid-19 victims are old and die from unrelated causes. Here we present twelve complete autopsies, including two rapid autopsies of young patients where the cause of death was Covid-19 ARDS. The main virus induced pathology was in the lung parenchyma and not in the airways. Most coagulation events occurred in the intra-alveolar and not in the intra-vascular space and the few thrombi were mainly composed of aggregated thrombocytes. The dominant inflammatory response was the massive accumulation of CD163+ macrophages and the disappearance of T killer, NK and B-cells. The virus was replicating in the pneumocytes and macrophages but not in bronchial epithelium, endothel, pericytes or stromal cells. The lung consolidations were produced by a massive regenerative response, stromal and epithelial proliferation and neovascularization. We suggest that thrombocyte aggregation inhibition, angiogenesis inhibition and general proliferation inhibition may have a roll in the treatment of advanced Covid-19 ARDS.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Histopathological Evaluation of Pulmonary Arterial Remodeling in COVID-19
Sergiy G. Gychka, Sofia I. Nikolaienko, … Yuichiro Suzuki·COVIDPeer-reviewed·May 28, 2025
- CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
P.-S. Sung, S.-P. Yang, … S.-L. Hsieh·bioRxiv·Feb 1, 2022
- Defective NET Clearance contributes to sustained FXII Activation in COVID-19-associated Pulmonary Thrombo-Inflammation
Hanna Englert, Chandini Rangaswamy, … Maike Frye·EBioMedicinePeer-reviewed·May 1, 2021
- Altered fibrin clot structure contributes to thrombosis risk in severe COVID-19
M. Wygrecka, A. Birnhuber, … K. T. Preissner·bioRxiv·Sep 17, 2021
- Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies
E. S. FitzGerald, A. M. Jamieson·bioRxiv·Jul 6, 2020
- Recombinant ACE2 Expression is Required for SARS-CoV-2 to Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
J. Nascimento Conde, W. R. Schutt, … E. R. Mackow·bioRxiv·Nov 10, 2020